Hancock Jaffe Laboratories Inc - Warrants (30/05/2023)
HJLIW
Get informed when a big investor buys or sells
+ FollowMarket Cap$98.32M
Close$
Share Statistics
| Market cap | $98.32 Million |
|---|---|
| Enterprise Value | $96.33 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-33.06 |
| Beta | 0 |
| Outstanding Shares | 654,000 |
Return
| Return on Equity | -79.24% |
|---|---|
| Return on Assets | -72.11% |
| Return on Invested Capital | -84.96% |
Valuation & Multiples
| P/E Ratio | -0.39 |
|---|---|
| PEG | 2.71 |
| Price to Sales | - |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.73 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hancock Jaffe Laboratories Inc
19 employeesHancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product c...